ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 60 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $15,300 | -15.1% | 16,541 | 0.0% | 0.00% | – |
| Q1 2023 | $18,030 | -35.1% | 16,541 | -13.1% | 0.00% | – |
| Q4 2022 | $27,787 | +20.8% | 19,032 | -9.5% | 0.00% | – |
| Q3 2022 | $23,000 | -28.1% | 21,032 | +10.5% | 0.00% | – |
| Q2 2022 | $32,000 | -30.4% | 19,032 | -14.4% | 0.00% | – |
| Q1 2022 | $46,000 | -43.9% | 22,232 | +1.5% | 0.00% | – |
| Q4 2021 | $82,000 | +134.3% | 21,906 | +223.4% | 0.00% | – |
| Q3 2021 | $35,000 | -84.1% | 6,774 | -86.9% | 0.00% | – |
| Q2 2021 | $220,000 | +158.8% | 51,729 | +222.2% | 0.00% | – |
| Q1 2021 | $85,000 | +2733.3% | 16,057 | +3150.4% | 0.00% | – |
| Q4 2020 | $3,000 | -40.0% | 494 | -19.7% | 0.00% | – |
| Q3 2020 | $5,000 | -98.3% | 615 | -97.9% | 0.00% | -100.0% |
| Q2 2020 | $287,000 | +889.7% | 28,621 | +330.8% | 0.00% | – |
| Q1 2019 | $29,000 | -74.1% | 6,643 | -66.0% | 0.00% | -100.0% |
| Q4 2018 | $112,000 | -17.0% | 19,525 | +95.7% | 0.00% | 0.0% |
| Q3 2018 | $135,000 | +309.1% | 9,978 | +261.7% | 0.00% | – |
| Q2 2018 | $33,000 | +3200.0% | 2,759 | +1279.5% | 0.00% | – |
| Q4 2017 | $1,000 | -50.0% | 200 | 0.0% | 0.00% | – |
| Q3 2017 | $2,000 | -88.9% | 200 | -92.0% | 0.00% | – |
| Q3 2016 | $18,000 | – | 2,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 12,025,999 | $66,263,000 | 2.30% |
| Abingworth LLP | 250,000 | $1,375,000 | 1.02% |
| Tekla Capital Management LLC | 1,466,368 | $8,080,000 | 0.31% |
| Rock Springs Capital Management LP | 875,000 | $4,821,000 | 0.28% |
| QVT Financial LP | 1,360,647 | $6,940,000 | 0.22% |
| Vident Investment Advisory, LLC | 232,641 | $1,282,000 | 0.13% |
| Hillhouse Capital Management | 1,190,476 | $6,560,000 | 0.13% |
| Orbimed Advisors | 1,914,660 | $10,550,000 | 0.12% |
| Granite Investment Partners, LLC | 195,571 | $1,078,000 | 0.07% |
| Monashee Investment Management LLC | 25,000 | $138,000 | 0.06% |